Combinatorial Mutant Library Enhances IgG Antibody Affinity via Phage Display | GenScript
Discover how GenScript’s combinatorial mutant library applied in phage display to benefit antibody engineering with over 100-fold increase in affinity by SPR ranking.
Learn MoreAccelerate Enzyme Optimization with GenScript and Allozymes | GenScript
Discover how GenScript and Allozymes are revolutionizing enzyme optimization through advanced DNA mutant libraries and high-throughput screening.
Learn MoreGenScript Poly(A) Strain: Overcoming Challenges in Pertaining Long Poly(A) Tail Sequence Integrity
Our study reveals GenScript's Poly(A) strains' unique ability to stabilize and refine poly(A) sequences, advancing precision and reliability in mRNA applications.
Learn MoreOur innovative GS-mK and GS-CMV vectors surpass traditional pUC57 and pVAX1 vectors in cloning efficiency, poly(A) tail stability......
Learn MoreNon-viral delivery promises a true alternative for cell therapy developers
This article features experts in the field of cell therapy development and explores why non-viral editing systems are ushering in the next wave of CRISPR-based cell therapies.
Learn MoreMastering the IHC Workflow: Key Insights for Successful Antibody Development with GenScript
Immunohistochemistry (IHC) is a vital technique that uses antibodies to locate antigens in tissues, with applications in cancer research and diagnostics.
Learn MoreApplication of NGS-Based Technology in sgRNA Sequencing QC
Discover how GenScript leverages new NGS-based technology to ensures cGMP sgRNA sequence quality
Learn More